Cell-Free Hemoglobin Concentration in Blood Prime Solution Is a Major Determinant of Cell-Free Hemoglobin Exposure during Cardiopulmonary Bypass Circulation in the Newborn.

导出 LinkOut

翻译打印收藏纠错

作者： Åsa,Jungner ^[1] ; Suvi,Vallius ^[2] ; Magnus,Gram ^[2] ; David,Ley ^[1]

作者单位： Pediatrics Lund, Department of Clinical Sciences Lund, Skåne University Hospital, Lund University, 222 41 Lund, Sweden. ^[1] Pediatrics Lund, Department of Clinical Sciences Lund, Lund University, 221 85 Lund, Sweden. ^[2]

关键词 cardiopulmonary bypass cell-free hemoglobin congenital heart defect haptoglobin hemopexin neonate

DOI 10.3390/jcm11144071

PMID 35887835

发布时间 2022-07-31

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of clinical medicine

2022年11卷14期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Cell-Free Hemoglobin Concentration in Blood Prime Solution Is a Major Determinant of Cell-Free Hemoglobin Exposure during Cardiopulmonary Bypass Circulation in the Newborn.

Journal of clinical medicine

相似文献

Journal of clinical medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Cell-Free Hemoglobin Concentration in Blood Prime Solution Is a Major Determinant of Cell-Free Hemoglobin Exposure during Cardiopulmonary Bypass Circulation in the Newborn.

Journal of clinical medicine

相似文献

Journal of clinical medicine

相关期刊

检索历史清除